Day: November 2, 2021

Banco Comercial Português informs about the completion of the sale of Banque Privée BCP (Suisse) SAAttachment2021 11 02 Conclusão Venda do Banque Privée_EN

2022 Grant Application Process Now Open for Up to $375,000 in Funding TEMPE, Ariz., Nov. 02, 2021 (GLOBE NEWSWIRE) — Align Technology, Inc. (NASDAQ: ALGN) today announced the opening of its 2022 Research Award Program to support clinical and scientific dental research in universities across the globe. This year, up to $375,000 will be awarded to university faculty for scientific and technological research initiatives to advance patient care in the fields of orthodontics and dentistry. Align Technology’s Research Award Program has funded approximately $2.4 million in research since the program’s inception in 2010. “The research supported by Align has provided valuable insights into important areas of oral healthcare and assessment, including intraoral scanning and patient experience, quality of life changes, as well as insights...

WOBURN, MA., Nov. 02, 2021 (GLOBE NEWSWIRE) — Biofrontera Inc. (“Biofrontera” or the “Company”) (Nasdaq: BFRI; BFRIW), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced the closing of its underwritten initial public offering of 3,600,000 units, each consisting of (i) one share of common stock and (ii) one warrant to purchase a share of common stock, at a public offering price per unit of $5.00. The underwriters exercised in full their option to purchase up to an additional 540,000 warrants. The warrants have an exercise price of $5.00 per share and are exercisable for a period of five years after the issuance date. The common stock and warrants are traded on the Nasdaq Capital Market under the ticker symbols “BFRI” and “BFRIW,” respectively. The gross proceeds to Biofrontera...

BURLINGTON, Mass., Nov. 02, 2021 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming virtual investor conferences. Stifel 2021 Virtual Healthcare ConferenceMonday, November 15, 2021David Roberts, President, will present at 8:40 AM ET Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services ForumThursday, November 18, 2021JJ Pellegrino, Chief Financial Officer, is scheduled to host a series of 1×1 meetings Piper Sandler 33rd Virtual Annual Healthcare ConferenceMonday, November 29 – Thursday, December 2, 2021A pre-recorded presentation by David Roberts, President, will be available About LeMaitre LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects...

PASCAGOULA, Miss., Nov. 02, 2021 (GLOBE NEWSWIRE) — Huntington Ingalls Industries (NYSE: HII) announced today that its Ingalls Shipbuilding division recently completed the first round of sea trials for San Antonio-class amphibious transport dock Fort Lauderdale (LPD 28). “Shipbuilding is about teamwork. Our shipbuilders work as a team with our Navy partners to make these ships ready to join the fleet,” said Steve Sloan, Ingalls’ LPD program manager. “The success we achieved this week will propel us into a strong finish as we prepare for acceptance trials later this year. We are proud of the work our shipbuilders have accomplished so far and look forward to finishing strong.” LPD 28 is named Fort Lauderdale to honor the Florida city’s historic ties to the U.S. Navy, which date back to the 1830s and include an important naval training...

1) CORRECT Image of Kratom PRBlister Pack Design for Kratom Infused version of Tauri-Gum™This Chewing Gum will be Infused with “Green Vein” Kratom Strain NEW YORK, NY, Nov. 02, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based diversified Life Sciences Company, today announced that it will proceed with the production of its proprietary, Green Vein Kratom (“Kratom”) infused, supplement chewing gum.  Each piece of Kratom infused Tauri-Gum™ will be infused with 20mg of “Green Vein” Kratom extract.  The proposed flavor for this product: Granny Smith Green Apple. Anticipated MSRP: $18.99 per Blister Pack / $182.00 per Retail Box The Company will procure both a standard Certificate of Analysis (“COA”) as well as a much more detailed lab...

Investor meeting on 10 November 2021 Eimskipafélag Íslands hf. will publish its third quarter 2021 results after market closing on Tuesday 9 November. Eimskip invites investors and market participants to a meeting where Vilhelm Thorsteinsson, CEO and María Björk Einarsdóttir, CFO, will present the third quarter results. The meeting will be held on Wednesday 10 November at 8:30 GMT at the Company‘s headquarters, Sundabakki 2, second floor. Participants are required to register their attendance before the end of 9 November by clicking here The meeting will also be webcasted live in Icelandic on www.eimskip.com/investors. Investors can send questions before and during the meeting to the email investors@eimskip.com. Documents and a recording of the meeting will be available at the company’s investor relations website, www.eimskip.is/investors. For...

Good evening, Please find enclosed BGHL October 2021 Newsletter. Best regards, Enquiries: Boussard & Gavaudan Investment Management, LLP Email: info@bgam-uk.com This document is issued by Boussard & Gavaudan Investment Management, LLP. which is authorised and regulated in the conduct of investment business by the Financial Conduct Authority in the United Kingdom. This document is for information purposes only and is not an offer to invest. Boussard & Gavaudan Holding Limited is a closed-ended investment company incorporated under the laws of Guernsey. Boussard & Gavaudan Holding Limited is registered with the Dutch Authority for Financial Markets as a collective investment scheme under article 1.107 of the Dutch Financial Markets Supervision Act. All investment is subject to risk. Past performance is no guarantee...

Good evening, Please find enclosed BGHL October 2021 Newsletter. Best regards, Enquiries: Boussard & Gavaudan Investment Management, LLP Email: info@bgam-uk.com This document is issued by Boussard & Gavaudan Investment Management, LLP. which is authorised and regulated in the conduct of investment business by the Financial Conduct Authority in the United Kingdom. This document is for information purposes only and is not an offer to invest. Boussard & Gavaudan Holding Limited is a closed-ended investment company incorporated under the laws of Guernsey. Boussard & Gavaudan Holding Limited is registered with the Dutch Authority for Financial Markets as a collective investment scheme under article 1.107 of the Dutch Financial Markets Supervision Act. All investment is subject to risk. Past performance is no guarantee...